Yusheng Wang

8PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 17, 2025
RC48 Induces Senescence in HER2-Expressing Colon Cancer Cells by Activating the CDKN1A-RB-E2F1 Pathway.

Jiaxue Wu, Qianqian Li, Xiangyu Cheng

|May 19, 2025
Efficacy observation of sequential TAS-102 following regorafenib as a later-line treatment in patients with metastatic colorectal cancer: a cohort study.

Chang Xu, Xiangyu Cheng, Changqing Liu

|Dec 23, 2024
A multicenter retrospective study of the combination of immune checkpoint inhibitors and chemotherapy regimens with or without liver metastasis for the first-line treatment of advanced gastric cancer.

Jing Ren, Ke Wang, Qianhao Meng

|Jul 18, 2024
Envafolimab Inhibits the Growth of Gastric Cancer Cells with Low PD-L1 Expression through the DDX20/NF-κB/TNF-α Signaling Pathway.

Zhuanxia Dong, Zefeng Yang, Jing Ren

|Feb 28, 2023
Survival comparison of first-line treatment regimens in patients with braf-mutated advanced colorectal cancer: a multicenter retrospective study.

Qianhao Meng, Jian Zhao, Yuanyuan Yu

|Jan 08, 2022
Efficacy of apatinib combined with FOLFIRI in the first-line treatment of patients with metastatic colorectal cancer.

Xuetong Rong, Haiyi Liu, Hongmei Yu

Pageof 2

Frequent Collaborators

4 joint publications

Yusheng Wang

3 joint publications

Jing Ren

2 joint publications

Chang Xu

1 joint publications

Zhuanxia Dong